Follicular Low Grade Non-Hodgkin's Lymphoma
1 clinical trials · Condition
◉ Watch Follicular Low Grade Non-Hodgkin's Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study of Intratumoral G100 With Or Without Pembrolizumab or Rituximab In Participants With Follicular Non-Hodgkin's Lymphoma (MK-3475-174/IMDZ-G142) (NCT02501473) | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2016-02-03 |
Track Follicular Low Grade Non-Hodgkin's Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.